Global immunohematology market is expected to reach USD 3.58 billion by 2028, at a CAGR of 5.92% from 2021 to 2028. Global Immunohematology market is witnessing a considerable growth owing to rise in awareness about the importance of blood transfusion, and increasing number of trauma cases.
Immunohematology is the study of antigens in blood cells and antibodies in the plasma. There are around 230 types of antigens present in the blood cells, which are categorized into two based on their chemical structure. They are carbohydrates and polypeptides. The patient who will go through transfusion has to be tested for ABO and RhD blood group. The presence of any antibodies will also be tested. That may cause reaction between plasma and donor blood cells. There are many tests to detect and identify the antibody present in the patient; they are from simple tube to gel tests to elution techniques etc. The same test will also identify the antigen present in the patient blood cell. The increasing cases of haematological diseases like anaemia, HIV etc. Increasing number of trauma cases, increasing awareness about the blood transfusion and related diseases are some of the factors that drive this market. Immunohematological tests is used for safe blood transfusion and haematopoietic tissue transplantation. This test prevent unwanted immune-related phenomena after transfusion or transplantation. The government in the developed and developing countries are investing in the blood bank. This factor is also driving the Immunohematology devices market. The technological advancement in this market have led to many new diagnostic approaches like the vitro study, which is the blood compatibility study of donor and receiver. Also, new developed testing devices and many new transfusion techniques have evolved with the technological advancement. The big players are working on improving the safety and the longevity of the blood stored in the blood bank with the advancement in immunohematology devices. However, High initial investment, lack of awareness about the technologies and the devices in the developing countries are acting as a restraint for the market.
Get an overview of this study by requesting a free sample
The increase in awareness among the people about the blood donation activities and the importance of blood transfusion in saving the life of the patient are the factors driving the immunohematology market. This awareness has increased the events associated with blood collection is generating a huge demand globally. This, in turn, drives the immunohematology market.
The increase in the number of cases for haematological diseases like anaemia, HIV etc., increasing number of trauma cases, increasing awareness about the blood transfusion and related diseases are some of the factors that drive this market. Immunohematological tests is used for safe blood transfusion and haematopoietic tissue transplantation. The government and private institutions are also taking initiatives for the establishment of many blood banks globally. This would certainly increase the demand for immunohematology devices and in turn, drive the market.
The increase in the demand for immunohematology device market and in the number of blood bank globally are some of the factors that are driving this market. However, there is a huge investment needed by the company in the R&D and technology department in order to come up with a new solution. This all factors are acting as a restraint for the market.
It also discovered that high-income countries, for instance, the USA & U.K., are responsible for an over 50 percent share in the blood donations collected globally. This shows lucrative opportunities for payers. A surge in the number ofblood banks, blood donors, and blood collection events in various countries will provide the growth of the market.
The global Immunohematology market has been segmented based on product, application, disease, end user and regions.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America is accounted for the highest market share of around 34.83% in 2020.
North America Immunohematology Market Share in 2020- 34.83%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global immunohematology industry.
In April 2018, Immucor announced Echo LumenaTM had got FDA clearance in the US. This is designed for the small to mid-volume laboratory segment. This gives better performance and clearer test results with its smallest benchtop footprint and the fastest type and screen turnaround time.
As per The Brainy Insights, the size of the immunohematology market was valued at USD 2.09 billion in 2020 and is anticipated to reach USD 3.58 billion by 2028.
Global immunohematology market is growing at a CAGR of 5.92% during the forecast period 2021-2028.
Theglobal Immunohematology market has been segmented based on product, application, disease, end user and regions. The HIV segment accounted for the largest share of the market in 2020.
The North America region emerged as the largest market for the immunohematology.
Growing awareness about the importance of blood transfusion is the key driving factor for the immunohematology market.
High initial investments, inadequate reimbursements of high-tech devices could hamper the market growth.
Blood donations in developed countries industries will provide huge opportunities to the market.
Key players are Siemens Healthcare GmbH, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Grifols, Immucor, Abbott laboratories.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By Route of Administration
4.3.3. Market Attractiveness Analysis By Application
4.3.4. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Rising incidences of multiple sclerosis
5.2.2. Increasing adoption of immunomodulator therapy for the treatment of Crohn's disease
5.3. Restrains
5.3.1. Adverse side effects of immunomodulator drugs
5.4. Opportunities
5.4.1. Increasing R&D activities
5.5. Challenges
5.5.1. Stringent government regulations for the approval and launch of the drug
6. Global Immunohematology Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Immunosuppressants
6.2.1. Calcineurin Inhibitors
6.2.2. Antibodies
6.2.3. Antimetabolites
6.2.4. Glucocorticoids
6.2.5. Others
6.3. Immunostimulants
6.3.1. Vaccines
6.3.2. Antibodies
6.3.3. Others
7. Global Immunohematology Market Analysis and Forecast, By Route of Administration
7.1. Segment Overview
7.2. Oral
7.3. Injectable
7.4. Intravenous
8. Global Immunohematology MarketAnalysis and Forecast, By Application
8.1. Segment Overview
8.2. Respiratory
8.3. Human Immunodeficiency Virus (HIV)
8.4. Oncology
8.5. Others
9. Global Immunohematology MarketAnalysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Immunohematology Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in Global Immunohematology Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Hoffmann-La Roche Ltd.
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Amgen Inc.
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. Abbott Laboratories
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Johnson & Johnson
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Novartis AG
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Bristol-Myers Squibb Company
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Merck & Co.
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Eli Lilly and Company
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Pfizer Inc.
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Biogen Inc.
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
11.11. Teva Pharmaceuticals
11.11.1. Business Overview
11.11.2. Company Snapshot
11.11.3. Company Market Share Analysis
11.11.4. Company Product Portfolio
11.11.5. Recent Developments
11.11.6. SWOT Analysis
11.12. Pandion Therapeutics, Inc.
11.12.1. Business Overview
11.12.2. Company Snapshot
11.12.3. Company Market Share Analysis
11.12.4. Company Product Portfolio
11.12.5. Recent Developments
11.12.6. SWOT Analysis
11.13. aTyr Pharma, Inc.
11.13.1. Business Overview
11.13.2. Company Snapshot
11.13.3. Company Market Share Analysis
11.13.4. Company Product Portfolio
11.13.5. Recent Developments
11.13.6. SWOT Analysis
List of Table
1. Global Immunohematology Market, By Type, 2018-2028 (USD Billion)
2. Global Immunosuppressants Immunohematology Market, By Region, 2018-2028 (USD Billion)
3. Global Immunostimulants Immunohematology Market, By Region, 2018-2028 (USD Billion)
4. Global Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
5. Global Oral Immunohematology Market, By Region, 2018-2028 (USD Billion)
6. Global Injectable Immunohematology Market, By Region, 2018-2028 (USD Billion)
7. Global Intravenous Immunohematology Market, By Region, 2018-2028 (USD Billion)
8. Global Immunohematology Market, By Application, 2018-2028 (USD Billion)
9. Global Respiratory Immunohematology Market, By Region, 2018-2028 (USD Billion)
10. Global Human Immunodeficiency Virus (HIV) Immunohematology Market, By Region, 2018-2028 (USD Billion)
11. Global Oncology Immunohematology Market, By Region, 2018-2028 (USD Billion)
12. Global Others Immunohematology Market, By Region, 2018-2028 (USD Billion)
13. Global Immunohematology Market, By Region, 2018-2028 (USD Billion)
14. Global Immunohematology Market, By North America, 2018-2028 (USD Billion)
15. North America Immunohematology Market, By Type, 2018-2028 (USD Billion)
16. North America Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
17. North America Immunohematology Market, By Application, 2018-2028 (USD Billion)
18. U.S. Immunohematology Market, By Type, 2018-2028 (USD Billion)
19. U.S. Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
20. U.S. Immunohematology Market, By Application, 2018-2028 (USD Billion)
21. Canada Immunohematology Market, By Type, 2018-2028 (USD Billion)
22. Canada Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
23. Canada Immunohematology Market, By Application, 2018-2028 (USD Billion)
24. Mexico Immunohematology Market, By Type, 2018-2028 (USD Billion)
25. Mexico Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
26. Mexico Immunohematology Market, By Application, 2018-2028 (USD Billion)
27. Europe Immunohematology Market, By Type, 2018-2028 (USD Billion)
28. Europe Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
29. Europe Immunohematology Market, By Application, 2018-2028 (USD Billion)
30. Germany Immunohematology Market, By Type, 2018-2028 (USD Billion)
31. Germany Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
32. Germany Immunohematology Market, By Application, 2018-2028 (USD Billion)
33. France Immunohematology Market, By Type, 2018-2028 (USD Billion)
34. France Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
35. France Immunohematology Market, By Application, 2018-2028 (USD Billion)
36. U.K. Immunohematology Market, By Type, 2018-2028 (USD Billion)
37. U.K. Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
38. U.K. Immunohematology Market, By Application, 2018-2028 (USD Billion)
39. Italy Immunohematology Market, By Type, 2018-2028 (USD Billion)
40. Italy Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
41. Italy Immunohematology Market, By Application, 2018-2028 (USD Billion)
42. Spain Immunohematology Market, By Type, 2018-2028 (USD Billion)
43. Spain Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
44. Spain Immunohematology Market, By Application, 2018-2028 (USD Billion)
45. Asia Pacific Immunohematology Market, By Type, 2018-2028 (USD Billion)
46. Asia Pacific Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
47. Asia Pacific Immunohematology Market, By Application, 2018-2028 (USD Billion)
48. Japan Immunohematology Market, By Type, 2018-2028 (USD Billion)
49. Japan Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
50. Japan Immunohematology Market, By Application, 2018-2028 (USD Billion)
51. China Immunohematology Market, By Type, 2018-2028 (USD Billion)
52. China Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
53. China Immunohematology Market, By Application, 2018-2028 (USD Billion)
54. India Immunohematology Market, By Type, 2018-2028 (USD Billion)
55. India Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
56. India Immunohematology Market, By Application, 2018-2028 (USD Billion)
57. South America Immunohematology Market, By Type, 2018-2028 (USD Billion)
58. South America Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
59. South America Immunohematology Market, By Application, 2018-2028 (USD Billion)
60. Brazil Immunohematology Market, By Type, 2018-2028 (USD Billion)
61. Brazil Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
62. Brazil Immunohematology Market, By Application, 2018-2028 (USD Billion)
63. Middle East and Africa Immunohematology Market, By Type, 2018-2028 (USD Billion)
64. Middle East and Africa Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
65. Middle East and Africa Immunohematology Market, By Application, 2018-2028 (USD Billion)
66. UAE Immunohematology Market, By Type, 2018-2028 (USD Billion)
67. UAE Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
68. UAE Immunohematology Market, By Application, 2018-2028 (USD Billion)
69. South Africa Immunohematology Market, By Type, 2018-2028 (USD Billion)
70. South Africa Immunohematology Market, By Route of Administration, 2018-2028 (USD Billion)
71. South Africa Immunohematology Market, By Application, 2018-2028 (USD Billion)
List of Figures
1. Global Immunohematology Market Segmentation
2. Immunohematology Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Immunohematology Market Attractiveness Analysis By Type
9. Global Immunohematology Market Attractiveness Analysis By Route of Administration
10. Global Immunohematology Market Attractiveness Analysis By Application
11. Global Immunohematology Market Attractiveness Analysis By Region
12. Global Immunohematology Market: Dynamics
13. Global Immunohematology Market Share By Type (2021 & 2028 )
14. Global Immunohematology Market Share By Route of Administration (2021 & 2028 )
15. Global Immunohematology Market Share By Application(2021 & 2028 )
16. Global Immunohematology Market Share by Regions (2021 & 2028 )
17. Global Immunohematology Market Share by Company (2020)
This study forecasts revenue at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global Immunohematology market on the basis of below mentioned segments:
Global Immunohematology Market by Product:
Global Immunohematology Market by Application:
Global Immunohematology Market by Disease:
Global Immunohematology Market by End User:
Global Immunohematology Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date